Miami Valley Hospital

P-C-MKT93775-mvhhero

Miami Valley Hospital has served Dayton and Southwest Ohio since 1890. We offer a wide range of advanced, innovative care from our campuses in downtown Dayton, at Miami Valley Hospital South in Centerville and at Miami Valley Hospital North in Englewood. Leading national organizations regularly recognize our quality care. We are the region’s most experienced Level I Trauma Center, providing the highest level of care for the most critically injured patients. We have earned accreditation as a Comprehensive Stroke Center for our specialized care of complex strokes. We have achieved Magnet® Recognition, nationally recognized as the highest standard for excellence in patient care. 

Location Information

One Wyoming Street
Dayton, OH 45409-2793

Directions >

Maps and parking >

Current ER Wait Time 39 Minutes*
I'm On My Way

Patients

Welcome! We want to make your hospital stay as comfortable and easy as possible. Learn what to expect before, during, and after your inpatient stay or outpatient visit.

Pricing, billing, and insurance >
Medical records >
Patient scheduling and registration >
About your hospital stay >

Visitors

Whether you’re a patient, family member, friend, or business partner, we welcome you to our campus. Get more information on parking, how to contact patients, rules for visiting patients, and the amenities we offer, including our food and dining options.

Learn more >

Visitor restrictions during COVID-19 >

P-C-MKT93775-campusdocsstack

Our Providers

Whether you’re looking for a primary care provider or a specialist, our physicians and advanced practice providers offer you advanced, compassionate care in a wide range of specialties. You’ll find them conveniently close to home and work.

See all providers
P-C-MKT93775-campusawardsstack

Awards

We’re proud to make a difference in our community. When others recognize our achievements, we know we’re fulfilling our mission. We’re grateful for the awards and recognition our hospital and people have earned.

See all awards

Upcoming Events

Wednesday, December 7, 2022

Weight Loss Surgery Seminar - Premier Weight Loss Solutions

Join us for a free weight loss surgery seminar

6:00 PM - 7:30 PM

Virtual Class

Thursday, December 8, 2022

Mobile Mammography

A mammogram is the best way to detect breast cancer early

10:00 AM - 6:00 PM

Friday, December 9, 2022

Mobile Mammography

A mammogram is the best way to detect breast cancer early

9:00 AM - 5:00 PM

Premier Health Family Care of Vandalia
600 Aviator Court
Vandalia, OH 45377

Latest News

Premier Health First in the Nation to Offer New Ovarian Cancer Clinical Trial

CENTERVILLE, Ohio (January 6, 2020) – Premier Health is the first health system in the United States to offer a new Phase III study for women who have been newly diagnosed with Stage III or IV BRCA negative ovarian cancer.

This clinical trial, KEYLYNK-001, examines how the addition of a cancer immunotherapy drug, Keytruda, and an oral prescription medication known as a PARP inhibitor, Lynparza, to standard chemotherapy affect progression-free survival (living with a disease without it worsening) and overall survival. 

“There is a growing body of data on the use of PARP inhibitors and immunotherapy in ovarian cancer with positive results,” said Michael Guy, MD, a board-certified gynecologic oncologist at Premier Gynecologic Oncology. “This new Phase III clinical trial will provide important insights in the use of these newer medications to improve outcomes in patients with newly diagnosed disease. We are proud to offer this exceptional study to our patients in the Miami Valley and honored to be the first in the country to provide such trials.”

Research has shown that the majority of women diagnosed with advanced stage ovarian cancer have a 39 percent five-year survival rate. Unfortunately, most women will die of the disease.

In the trial, all study subjects will receive six cycles of standard chemotherapy with or without Keytruda. Patients also undergo surgery for their cancer at the discretion of a physician during this initial phase. After the first six cycles, patients will be randomly assigned for up to two years to one of three arms of the study: Keytruda and a Lynparza pill; Keytruda and a Lynparza placebo; or Keytruda and Lynparza placebos.

The Phase III study is another way that Premier Health’s comprehensive cancer care team offers patients and their families compassionate, specialized care. Located at Miami Valley Hospital South, the physicians at Premier Gynecologic Oncology provide treatment for women with cancer and treatment-related symptoms, complex pelvic surgical problems, gynecologic cancers, and palliative care.

This study will eventually be offered at 50 locations across the United States. Premier Health is the country’s first and only site currently offering this trial.

*The current wait time is an estimated wait time before a person sees a physician and is not a guarantee. It is based on patient activity (how many patients are being treated and the severity of their injuries) within the last hour, and it is subject to change at any moment. If you are experiencing an emergency, call 911.